goat polyclonal anti ncam (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
95
Structured Review
R&D Systems
goat polyclonal anti ncam
Goat Polyclonal Anti Ncam, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 675 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+polyclonal+ncam/Goat+Anti-Rat+IgG+Antibody/pm39859157-346-72-75
Average 95 stars, based on 675 article reviews
Goat Polyclonal Anti Ncam, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 675 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+polyclonal+ncam/Goat+Anti-Rat+IgG+Antibody/pm39859157-346-72-75
Average 95 stars, based on 675 article reviews
goat polyclonal anti ncam - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Marker:Article Title: Phosphorylated α-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy. Article Snippet: Multiple system atrophy (MSA) is characterized by accumulation of phosphorylated α-synuclein (p-syn) as glial cytoplasmic inclusions in the brain and a specific biomarker for this disorder is urgently needed.. We aimed at investigating if p-syn can also be detected in skin Remak non-myelinating Schwann cells (RSCs) as Schwann cell cytoplasmic inclusions (SCCi) and may represent a reliable clinical biomarker for MSA.. This cross-sectional diagnostic study evaluated skin p-syn in 96 patients: 46 with probable MSA (29 with parkinsonism type MSA and 17 with cerebellar type MSA), 34 with Parkinson’s disease (PD) and 16 with dementia with Lewy bodies (DLB). Staining:Article Title: Phosphorylated α-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy. Article Snippet: Multiple system atrophy (MSA) is characterized by accumulation of phosphorylated α-synuclein (p-syn) as glial cytoplasmic inclusions in the brain and a specific biomarker for this disorder is urgently needed.. We aimed at investigating if p-syn can also be detected in skin Remak non-myelinating Schwann cells (RSCs) as Schwann cell cytoplasmic inclusions (SCCi) and may represent a reliable clinical biomarker for MSA.. This cross-sectional diagnostic study evaluated skin p-syn in 96 patients: 46 with probable MSA (29 with parkinsonism type MSA and 17 with cerebellar type MSA), 34 with Parkinson’s disease (PD) and 16 with dementia with Lewy bodies (DLB). |
